HomeTOP STORIESCannara Biotech GAAP EPS of C$0.03, revenue of C$25.1M Cannara Biotech GAAP EPS of C$0.03, revenue of C$25.1M By rogerjudd January 27, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleVail Resorts gains as investor pushes for CEO ouster, board resetNext articleNYC mayor slams ‘despicable act of antisemitism’ after Israeli restaurant vandalized with ‘messages of hate’ latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
